Vitamin D and Cardiometabolic Disease: From Observation to Intervention

Yiqing Song, Lu Wang

Research output: Contribution to journalReview article

Abstract

Vitamin D deficiency has become a major public health problem worldwide due to its increasing prevalence and potential health risks. There is growing evidence from experimental studies to suggest that vitamin D may influence risk of cardiometabolic disease through multiple pathways, including inhibition of the release of proinflammatory cytokines; regulation of the renin-angiotensin system; and favorable effects on lipids, blood pressure, insulin secretion and action, and thrombosis. Human observational data, primarily from cross-sectional studies, have shown that low dietary vitamin D intake or vitamin D levels are inversely related to various cardiometabolic risk factors. Prospective studies have suggested the relationship between low 25(OH)D and increased risk of cardiometabolic disease, including hypertension, type 2 diabetes, and cardiovascular disease. Evidence from small randomized trials and post-hoc analyses of large clinical trials for the effect of vitamin D supplements on cardiometabolic risk factors, however, remains inconsistent. This article aims to summarize epidemiologic data on the relationship between vitamin D and major cardiometabolic disease and highlight the challenges in translating observational evidence to future intervention studies.

Original languageEnglish (US)
Pages (from-to)55-63
Number of pages9
JournalCurrent Nutrition Reports
Volume1
Issue number2
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

vitamin D
Vitamin D
Observation
risk factors
renin-angiotensin system
vitamin D deficiency
Vitamin D Deficiency
insulin secretion
thrombosis
Renin-Angiotensin System
prospective studies
noninsulin-dependent diabetes mellitus
cross-sectional studies
Type 2 Diabetes Mellitus
hypertension
cardiovascular diseases
blood pressure
clinical trials
public health
Thrombosis

Keywords

  • 25-hydroxyvitamin D (25[OH]D)
  • Adiposity
  • Blood pressure
  • Cardiometabolic disease
  • Cardiometabolic risk factors
  • Hypertension
  • Insulin secretion and sensitivity
  • Metabolic syndrome
  • Renin-angiotensin system (RAS)
  • Systemic inflammation
  • Type 2 diabet
  • Vitamin D

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Vitamin D and Cardiometabolic Disease : From Observation to Intervention. / Song, Yiqing; Wang, Lu.

In: Current Nutrition Reports, Vol. 1, No. 2, 01.01.2012, p. 55-63.

Research output: Contribution to journalReview article

@article{6d1a376f259d4e508cac44a61850f23b,
title = "Vitamin D and Cardiometabolic Disease: From Observation to Intervention",
abstract = "Vitamin D deficiency has become a major public health problem worldwide due to its increasing prevalence and potential health risks. There is growing evidence from experimental studies to suggest that vitamin D may influence risk of cardiometabolic disease through multiple pathways, including inhibition of the release of proinflammatory cytokines; regulation of the renin-angiotensin system; and favorable effects on lipids, blood pressure, insulin secretion and action, and thrombosis. Human observational data, primarily from cross-sectional studies, have shown that low dietary vitamin D intake or vitamin D levels are inversely related to various cardiometabolic risk factors. Prospective studies have suggested the relationship between low 25(OH)D and increased risk of cardiometabolic disease, including hypertension, type 2 diabetes, and cardiovascular disease. Evidence from small randomized trials and post-hoc analyses of large clinical trials for the effect of vitamin D supplements on cardiometabolic risk factors, however, remains inconsistent. This article aims to summarize epidemiologic data on the relationship between vitamin D and major cardiometabolic disease and highlight the challenges in translating observational evidence to future intervention studies.",
keywords = "25-hydroxyvitamin D (25[OH]D), Adiposity, Blood pressure, Cardiometabolic disease, Cardiometabolic risk factors, Hypertension, Insulin secretion and sensitivity, Metabolic syndrome, Renin-angiotensin system (RAS), Systemic inflammation, Type 2 diabet, Vitamin D",
author = "Yiqing Song and Lu Wang",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/s13668-012-0014-2",
language = "English (US)",
volume = "1",
pages = "55--63",
journal = "Current Nutrition Reports",
issn = "2161-3311",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Vitamin D and Cardiometabolic Disease

T2 - From Observation to Intervention

AU - Song, Yiqing

AU - Wang, Lu

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Vitamin D deficiency has become a major public health problem worldwide due to its increasing prevalence and potential health risks. There is growing evidence from experimental studies to suggest that vitamin D may influence risk of cardiometabolic disease through multiple pathways, including inhibition of the release of proinflammatory cytokines; regulation of the renin-angiotensin system; and favorable effects on lipids, blood pressure, insulin secretion and action, and thrombosis. Human observational data, primarily from cross-sectional studies, have shown that low dietary vitamin D intake or vitamin D levels are inversely related to various cardiometabolic risk factors. Prospective studies have suggested the relationship between low 25(OH)D and increased risk of cardiometabolic disease, including hypertension, type 2 diabetes, and cardiovascular disease. Evidence from small randomized trials and post-hoc analyses of large clinical trials for the effect of vitamin D supplements on cardiometabolic risk factors, however, remains inconsistent. This article aims to summarize epidemiologic data on the relationship between vitamin D and major cardiometabolic disease and highlight the challenges in translating observational evidence to future intervention studies.

AB - Vitamin D deficiency has become a major public health problem worldwide due to its increasing prevalence and potential health risks. There is growing evidence from experimental studies to suggest that vitamin D may influence risk of cardiometabolic disease through multiple pathways, including inhibition of the release of proinflammatory cytokines; regulation of the renin-angiotensin system; and favorable effects on lipids, blood pressure, insulin secretion and action, and thrombosis. Human observational data, primarily from cross-sectional studies, have shown that low dietary vitamin D intake or vitamin D levels are inversely related to various cardiometabolic risk factors. Prospective studies have suggested the relationship between low 25(OH)D and increased risk of cardiometabolic disease, including hypertension, type 2 diabetes, and cardiovascular disease. Evidence from small randomized trials and post-hoc analyses of large clinical trials for the effect of vitamin D supplements on cardiometabolic risk factors, however, remains inconsistent. This article aims to summarize epidemiologic data on the relationship between vitamin D and major cardiometabolic disease and highlight the challenges in translating observational evidence to future intervention studies.

KW - 25-hydroxyvitamin D (25[OH]D)

KW - Adiposity

KW - Blood pressure

KW - Cardiometabolic disease

KW - Cardiometabolic risk factors

KW - Hypertension

KW - Insulin secretion and sensitivity

KW - Metabolic syndrome

KW - Renin-angiotensin system (RAS)

KW - Systemic inflammation

KW - Type 2 diabet

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85057648467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057648467&partnerID=8YFLogxK

U2 - 10.1007/s13668-012-0014-2

DO - 10.1007/s13668-012-0014-2

M3 - Review article

AN - SCOPUS:85057648467

VL - 1

SP - 55

EP - 63

JO - Current Nutrition Reports

JF - Current Nutrition Reports

SN - 2161-3311

IS - 2

ER -